Pharmaceutical Sciences 2018 Vandetanib in anaplastic thyroid cancer-Poupak Fallahi-University of Pisa

摘要

Thyroid cancer accounts for about 1% of all cancers1 and isthe most common malignant endocrinological tumor. In thelast few decades, an increased TC incidence has been shown(from 10.3 per 100,000 individuals in 2000 to 21.5 per100,000 individuals in 2012), especially for the papillarycarcinoma, while mortality seems not be changed.